4basebio PLC (ETR:88Q)
Germany · Delayed Price · Currency is EUR 9.00
+0.55 (6.51%)
Oct 10, 2025, 7:49 AM CET
4basebio Revenue
4basebio had revenue of 1.17 million GBP in the half year ending June 30, 2025, with 393.28% growth. This brings the company's revenue in the last twelve months to 1.78 million, up 198.49% year-over-year. In the year 2024, 4basebio had annual revenue of 933 thousand with 84.39% growth.
Revenue (ttm)
1.78M GBP
Revenue Growth
+198.49%
P/S Ratio
67.66
Revenue / Employee
16.17K GBP
Employees
110
Market Cap
140.42M EUR
Revenue Chart
* This company reports financials in GBP.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 933.00K | 427.00K | 84.39% |
| Dec 31, 2023 | 506.00K | 238.00K | 88.81% |
| Dec 31, 2022 | 268.00K | -70.00K | -20.71% |
| Dec 31, 2021 | 338.00K | -124.00K | -26.84% |
| Dec 31, 2020 | 462.00K | -346.00K | -42.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 46.17B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.28B |
| Merck KGaA | 21.22B |
| Fresenius Medical Care AG | 19.52B |
| Sartorius Aktiengesellschaft | 3.47B |
| Redcare Pharmacy NV | 2.68B |
| Fielmann Group AG | 2.40B |